Cortex Pharmaceuticals Reviews

0 Reviews
0 Reviews

Recommend to a friend
Approve of CEO
(no image)
Mark A. Varney
0 Ratings

Cortex Pharmaceuticals Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Edit Profile
Headquarters Irvine, CA
Size 6 to 15 Employees
Founded Unknown
Type Company - Public (CORX)
Industry Biotech & Pharmaceuticals
Revenue $10 to $25 million (USD) per year

Cortex Pharmaceuticals develops drugs to treat neurodegenerative and psychiatric disorders. Its research focuses on the AMPA receptor, which facilitates communication between nerve cells; the firm's Ampakine compounds may enhance this receptor's activity. Cortex's tends to develop candidates and then license the technologies to larger firms for diseases that require clinical and commercialization infrastructure to develop drugs for large markets (Alzheimer's disease, for instance). In turn, it will focus its internal research efforts on developing more compounds for niche... More

Worked for Cortex Pharmaceuticals? Contribute to the Community!